Facility will support lead generation in the near-term and will later be leveraged for collaborations.

f-star is opening a research site in Cambridge, U.K. and plans to begin operations on April 15. The facility will be located at the Babraham Research Campus.

Researchers located here will be responsible for lead generation based on the company’s Modular Antibody Technology. f-star also plans to use the building for future research related to the collaborations with pharma and biotech partners.

Previous articleRaven Inks Manufacturing Deal with CMC to Help Advance RAV 18 into the Clinic
Next articleTPG Biotech to Fund Development of Two Drugs from JCR